GBIO - Biotech Soars After Strategic Reorganization Announcement

2023-11-29 16:27:17 ET

A Massachusetts-based %Biotech company captured the attention of the trading community on Wednesday after it was announced that the company will undergo a strategic reorganization to prioritize investment in the development of its cell-targeted lipid nanoparticle (ctLNP) delivery system for wholly-owned programs in extrahepatic cell types, according to the release.

Traders saw this as a bullish signal for shares of %GenerationBioCo (Nasdaq: GBIO) as shares of this small cap traded up to $1.19/share (+6.25%) at the session high. This move could be an indication of things to come seeing that the biotech sector has been on a tear lately and this stock certainly has room to run.

Generation Bio Co (Nasdaq: ) is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina related diseases.

About AllPennyStocks.com Media Inc.:

AllPennyStocks.com Media, Inc., founded in 1999, is one of North America’s largest and most comprehensive small-cap / penny stock financial portals.